Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Papua New Guinea.
Press releases published on September 22, 2025
SAIC Announces Proposed Offering of $500.0 Million in Senior Notes
RESTON, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) (“SAIC”), a premier Fortune 500 technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence …
Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
CAMBRIDGE, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that longer-term data from the …
Xtract One Selected by Manor Independent School District to Strengthen Security Long-Term Across District Campuses
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Manor Independent School District (“Manor …
Plus Therapeutics Announces Additional $1.9 Million Advance Payment from CPRIT
Non-dilutive payment is part of $17.6 million award granted for the Company’s leptomeningeal cancer targeted radiotherapeutic development program HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical …
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one late breaking clinical trials oral …
XOMA Royalty Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock …
Aptose and Hanmi Pharmaceutical Extend Loan Agreement to Continue Development of Tuspetinib in Triplet Therapy for AML
SAN DIEGO and TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Starpharma Announces a Collaboration and License Agreement with Genentech
MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology company, today announced the signing of a collaboration and license agreement with Genentech, a member of the Roche Group, …
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
WAYNE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the appointment …
Reitar Logtech Partners with NEXX to Launch Global Strategic Cooperation
First Project to Establish a Smart E-commerce Fulfillment Center in Qatar Set to Commence Full Operations by Year-End HONG KONG, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Reitar Logtech Holdings Limited (NASDAQ: RITR) (“Reitar” or “The Company”), a Nasdaq listed …
Crystal Art Gallery Increases Ecommerce Fulfillment 5x with Descartes Sellercloud™
ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that California-based Crystal Art Gallery, a leading global omnichannel supplier …
Sierra Space Achieves Perfect CMMC Level 2 Score with eSHARE as Strategic Partner
WALTHAM, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Sierra Space met CMMC Level 2 with a perfect score—110 out of 110 controls satisfied—demonstrating an uncompromising commitment to cybersecurity and regulatory compliance. Strategic Partnership with eSHARE …
SEALSQ and the Seoul Metropolitan Government Sign MoU to Establish a Post-Quantum Semiconductor Personalization, Research and Design Center in Seoul
Seoul, South Korea / Geneva, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software …
CellProthera announces peer-reviewed publication of its Phase I/IIb results on safety and feasibility of ProtheraCytes® in patients with severe heart failure post-myocardial Infarction
JACC-Heart Failure publication highlights high-quality cell expansion, good tolerability, manageable procedural risk and encouraging early signals of functional effects. Mulhouse, France – [DATE] – CellProthera today announced that its open-label …
CellProthera annonce la publication de ses résultats de phase I/IIb sur la sécurité et la faisabilité des ProtheraCytes® chez des patients souffrant d'insuffisance cardiaque sévère après un infarctus du myocarde.
La publication du JACC-Heart Failure souligne la haute qualité de l'expansion cellulaire, la bonne tolérance, le risque procédural gérable et les signes précoces encourageants d'effets fonctionnels. Mulhouse, France – 10 septembre 2025 - CellProthera a …
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s ( …
First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease
Research Triangle Park, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment of moderate-stage Parkinson’s disease in the REGENERATE-PD …
Vocalbeats.AI Strengthens Commitment to AI Advancement as Sponsor of Singapore’s FutureChina Global Forum 2025
FutureChina Global Forum 2025 convened leaders from more than 25 countries, with Sponsor Vocalbeats.AI championing a future where artificial intelligence strengthens human connection. SINGAPORE, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Singapore AI innovation …
HKPC and GPTBots.ai: Joining Forces to Drive Intelligent Transformation for Hong Kong Enterprises
HONG KONG, Sept. 22, 2025 (GLOBE NEWSWIRE) -- GPTBots.ai, the enterprise AI platform of Aurora Mobile (NASDAQ: JG), co-hosted the highly anticipated thematic course "AI Agents Drive Intelligent Transformation" with the Hong Kong Productivity Council (HKPC …
Helio Diagnostics: A European CDMO dedicated to In Vitro Diagnostics
Helio Diagnostics: A European CDMO dedicated to In Vitro Diagnostics Helio Diagnostics is backed by a team with 25+ years of experience in the development and manufacturing of complex diagnostic devices. Marseille, France – September 22, 2025 – Helio …